Clinical Trial Update: A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas [Phase 1]

View source ↗

Summary

CS5001 is being evaluated in a Phase 1 study for patients with advanced solid tumors and advanced lymphoma, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumor

Drugs mentioned

• CS5001

Snippet

Sponsor: CStone Pharmaceuticals | Conditions: Advanced Solid Tumor, Advanced Lymphoma | Phase 1 | Status: RECRUITING